Logo image of NU.CA

NEUTRISCI INTERNATIONAL INC (NU.CA) Stock Earnings & Estimates

Canada - TSX Venture Exchange - TSX-V:NU - CA64129Y1079 - Common Stock

0.005 CAD
0 (0%)
Last: 5/7/2024, 7:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022
Revenue
YoY % growth
NU.CA revenue by date.NU.CA revenue by date.
74.57K
-22.76%
80.89K
8.48%
457.75K
465.89%
EBITDA
YoY % growth
NU.CA ebitda by date.NU.CA ebitda by date.
-1.917M
-16.56%
-1.419M
26.00%
-653.78K
53.91%
EBIT
YoY % growth
NU.CA ebit by date.NU.CA ebit by date.
-1.944M
-17.86%
-1.464M
24.72%
-691.04K
52.79%
Operating Margin
NU.CA operating margin by date.NU.CA operating margin by date.
-2,607.24%-1,809.49%-150.96%
EPS
YoY % growth
NU.CA eps by date.NU.CA eps by date.
N/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q3 2023
Q2Q % growth
2.73K
-46.99%
%
Q2 2023
Q2Q % growth
2.99K
-98.69%
%
Q1 2023
Q2Q % growth
3.09K
-98.22%
%
Q4 2022
Q2Q % growth
51.17K
97.80%
%
Q2 2022
Q2Q % growth
228.09K
314.56%
%
Q4 2021
Q2Q % growth
25.87K
292.56%
%
Q3 2021
Q2Q % growth

-100.00%
%
Q2 2021
Q2Q % growth
55.02K
1,039.13%
%
Q1 2021
Q2Q % growth

-100.00%
%
NU.CA Yearly Revenue VS EstimatesNU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 100K 200K 300K 400K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A